HCA Healthcare Inc (HCA) SVP Sandra L. Morgan Sells 1,913 Shares

Share on StockTwits

HCA Healthcare Inc (NYSE:HCA) SVP Sandra L. Morgan sold 1,913 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $122.29, for a total value of $233,940.77. Following the transaction, the senior vice president now owns 6,593 shares of the company’s stock, valued at $806,257.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of HCA stock opened at $139.71 on Monday. The company has a market capitalization of $48.08 billion, a price-to-earnings ratio of 14.30, a price-to-earnings-growth ratio of 1.16 and a beta of 0.80. HCA Healthcare Inc has a fifty-two week low of $93.03 and a fifty-two week high of $147.42.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.59 by $0.40. The business had revenue of $12.27 billion during the quarter, compared to the consensus estimate of $12.10 billion. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the company posted $2.12 earnings per share. On average, equities analysts anticipate that HCA Healthcare Inc will post 10.02 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be issued a $0.40 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date is Thursday, February 28th. HCA Healthcare’s payout ratio is presently 14.33%.

A number of equities analysts have recently issued reports on the company. Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, December 11th. SunTrust Banks raised their price objective on HCA Healthcare to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Credit Suisse Group raised their price objective on HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a research report on Thursday, November 1st. Stephens assumed coverage on HCA Healthcare in a research report on Monday, January 14th. They set an “overweight” rating and a $143.00 price objective for the company. Finally, Argus raised their price objective on HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Tuesday, November 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and an average price target of $148.43.

Hedge funds have recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $25,000. Moody National Bank Trust Division bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $27,000. Trust Co. of Vermont increased its holdings in shares of HCA Healthcare by 165.3% during the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after acquiring an additional 205 shares in the last quarter. Csenge Advisory Group bought a new stake in shares of HCA Healthcare during the third quarter valued at approximately $48,000. Finally, Private Capital Group LLC increased its holdings in shares of HCA Healthcare by 346.0% during the fourth quarter. Private Capital Group LLC now owns 446 shares of the company’s stock valued at $56,000 after acquiring an additional 346 shares in the last quarter. Institutional investors and hedge funds own 69.98% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Macon Daily and is the property of of Macon Daily. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://macondaily.com/2019/02/04/hca-healthcare-inc-hca-svp-sandra-l-morgan-sells-1913-shares.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: What is the quiet period?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply